Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

3.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.8K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functionalizing Injectable Hydrogels with Cobalt-Based Metallacarboranes for Targeted Delivery in Triple-Negative Breast Cancer.

Chembiochem : a European journal of chemical biology·2025
Same author

Mechanobiological cues to bone cells during early metastasis drive later osteolysis: A computational mechanoregulation framework prediction.

Mechanobiology in medicine·2025
Same author

Evaluation of human adipose-derived stromal cell behaviour following exposure to Tamoxifen.

Tissue & cell·2022
Same author

Temporal and spatial changes in bone mineral content and mechanical properties during breast-cancer bone metastases.

Bone reports·2022
Same author

A comparative analysis of extracellular vesicles (EVs) from human and feline plasma.

Scientific reports·2022
Same author

Implementing subtype-specific pre-clinical models of breast cancer to study pre-treatment aspirin effects.

Cancer medicine·2022

Related Experiment Video

Updated: Mar 1, 2026

Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

26.2K

Engineering Exosomes for Cancer Therapy.

Katie E Gilligan1, Róisín M Dwyer2

  • 1Discipline of Surgery, Lambe Institute for Translational Research, National University of Ireland Galway (NUIG), Galway H91 YR71, Ireland. K.GILLIGAN3@nuigalway.ie.

International Journal of Molecular Sciences
|May 25, 2017
PubMed
Summary

Exosomes, tiny vesicles secreted by cells, show promise as cancer therapeutics. Engineering these extracellular vesicles can target tumors, reduce cancer spread, and enhance treatment efficacy, offering new hope for metastatic cancer patients.

Keywords:
cancerelectroporationexosomeslipofectionmicroRNAtherapyviral

More Related Videos

Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
09:30

Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes

Published on: May 24, 2019

7.9K
An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
10:33

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue

Published on: February 3, 2023

1.7K

Related Experiment Videos

Last Updated: Mar 1, 2026

Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

26.2K
Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
09:30

Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes

Published on: May 24, 2019

7.9K
An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
10:33

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue

Published on: February 3, 2023

1.7K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Metastatic cancer causes millions of deaths annually, necessitating novel therapeutic strategies.
  • Exosomes are natural intercellular vesicles capable of stable drug and biomolecule transfer.
  • Exosomes are gaining interest as potential tumor-targeted delivery vehicles for cancer therapy.

Purpose of the Study:

  • To review the potential of exosomes as therapeutic vehicles for metastatic cancer.
  • To explore methods for engineering exosome content and targeting capabilities.
  • To summarize promising preclinical results of exosome-based cancer therapies.

Main Methods:

  • Engineering parent cells (viral/non-viral) to produce modified exosomes.
  • Direct manipulation of exosome content post-secretion.
  • Review of studies demonstrating exosome efficacy in preclinical cancer models.

Main Results:

  • Engineered exosomes demonstrated decreased tumor cell invasion, migration, and proliferation.
  • Enhanced anti-tumor immune responses were observed with exosome treatment.
  • Increased cancer cell death and sensitivity to chemotherapy were reported.

Conclusions:

  • Exosomes hold significant promise as versatile therapeutic vehicles for cancer treatment.
  • Engineering exosomes offers a powerful strategy for developing targeted cancer therapies.
  • Clinical translation requires standardized methods for exosome manipulation, isolation, and characterization.